The 5 natural antibiotics from nature: evidence, limitations, and practical indications

IN BRIEF

• Some natural substances show antimicrobial activity in the laboratory; the strength and clinical relevance vary greatly.
• Allicin (garlic), carvacrol (oregano), Manuka honey, and other compounds have plausible biological mechanisms but are not equivalent to prescribed antibiotics.
• Colloidal silver may have antimicrobial effects in vitro but carries documented risks (e.g., argyria) and limited clinical data for systemic use.
• Quality, form, dose, and context (topical vs. oral, standardized product vs. homemade) determine the results.

Abstract: What does science say?

Brief definition: "Natural antibiotics" refer to substances of plant or animal origin with antimicrobial activity demonstrated in in vitro studies, animal models, or small-scale clinical studies. Evidence shows that compounds such as allicin (garlic), carvacrol (oregano oil), components of Manuka honey, and some olive phenols have antimicrobial activity in the laboratory. However, most data come from in vitro studies or experimental models: the clinical effect in humans strongly depends on concentration, preparation form (oil, extract, medicinal honey), route of administration, and the nature of the infection. Some natural solutions may supplement topical wound treatment or act synergistically with antibiotics in specific contexts; others, such as the systemic use of colloidal silver, carry documented risks. Observational and experimental evidence suggests biological plausibility but does not replace strong causal evidence for many clinical indications.

MAIN SECTION

Main Natural Antibiotics: Overview and Mechanisms

Many natural products contain molecules with measurable antimicrobial activity in the laboratory. These actions may include: damage to the microbial membrane, inhibition of essential enzymes, oxidative action, and interference with biofilm formation. It is important to distinguish between: in vitro evidence (cultures and MIC assays), preclinical in vivo studies (animal models), and human clinical studies. Differences in concentration, purity, and vehicle (oil, hydroalcoholic extract, medical honey) radically influence the observed efficacy. Below, we examine the five products most frequently cited in popular and scientific literature.

GARLIC (allicin)

Allicin is a sulfur compound synthesized when garlic is crushed; it shows broad antimicrobial activity in laboratory tests and can interfere with microbial enzymes sensitive to thiol groups. Classic experimental studies and reviews have documented allicin's activity against gram-positives and gram-negatives, including some resistant strains in vitro [1]. Subsequent research has also evaluated allicin in combination with classic antibiotics, observing additive or synergistic effects in some cases, but with marked variability between strains and test conditions [2]. The chemical stability of allicin is limited: it degrades easily in food or biological matrices, affecting bioavailability and the actual effect when consumed as food or a supplement. Therefore, while laboratory evidence is solid, translation into standardized oral clinical efficacy requires products with controlled characterization and dosages.

COLLOIDAL SILVER

The term "colloidal silver" refers to small silver particles or ions in suspension. Silver has documented antimicrobial properties in the laboratory and is used in topical medical products (e.g., silver-containing dressings) for the prevention of local infections. However, ingestion or systemic use of non-standardized colloidal solutions is associated with known risks, including argyria (permanent deposition of silver in tissues with skin discoloration) and potential systemic toxic effects. Recent clinical reports and reviews highlight cases of argyria related to the use of silver-based products and a lack of solid evidence supporting systemic efficacy for common infections; therefore, the safety and risk/benefit ratio of its systemic use remain controversial [3]. Topical use in controlled clinical settings differs from oral intake of commercial or DIY products.

OREGANO OIL (carvacrol)

Oregano essential oil contains carvacrol and thymol, phenolic compounds with demonstrated antimicrobial action on many bacterial and fungal species. Studies on biofilms and cultures show that carvacrol can reduce bacterial loads and interfere with biofilm development or stability at defined concentrations [4]. Structural research indicates how specific chemical characteristics of carvacrol determine its antimicrobial activity through interaction with microbial membranes and proteins [5]. However, effective concentrations in vitro may not be achievable orally without side effects; formulation (e.g., diluted oil for topical use) and standardization of the carvacrol percentage are key elements for any practical evaluation.

Echinacea

Echinacea has historically been used for respiratory symptoms and as an immunomodulator. Systematic reviews of randomized clinical trials show heterogeneous results: some preparations and dosages show a modest preventive effect or a reduction in the duration of cold symptoms, while others find no significant benefit. Variability is largely attributable to species-specific differences in Echinacea, plant parts used (root vs. aerial part), extraction methods, and quality of clinical studies. A recent Cochrane review summarizes this uncertainty and advises interpreting the data with caution [6].

MANUKA HONEY

Manuka honey (produced from the nectar of Leptospermum scoparium, New Zealand) possesses antibacterial properties linked to distinct chemical components (e.g., methylglyoxal) and osmotic activity. In vitro studies show activity against S. aureus, including MRSA strains, and reduction of biofilms; synergistic effects with some antibiotics have also been reported in laboratory studies, suggesting a potential role as a complementary topical therapy in skin lesions and infected wounds [7][8]. Large-scale clinical evidence remains limited, and product quality (medical/sterile grade vs. commercial honey) is crucial for safe and reliable application.

PRACTICAL SECTION

What it means in practice

1) Distinguish topical and systemic use: for many natural substances (Manuka honey, silver-containing applications), topical use in clinical contexts may be appropriate and supported by local data; oral use in non-standardized form often has no proven efficacy and may carry risks. 2) Product standardization and quality matter: observed effects depend on the concentration of the active ingredient (e.g., allicin, carvacrol, MGO in honey) and purity. 3) Do not replace prescribed therapies: for moderate or severe infections, clinically indicated antibiotics remain the standard of care; natural remedies may have a complementary or preventive role only in well-justified contexts and with clinical supervision. 4) Interactions and safety: some remedies may interfere with medications or have side effects (e.g., silver: argyria; undiluted essential oil: irritation). When considering a natural remedy, discussing it with your doctor is the most prudent choice.

KEY POINTS TO REMEMBER

• Many natural substances show antimicrobial activity in the laboratory, but clinical evidence is often limited or contextual.
• The product form, concentration, and mode of use (topical vs. oral) determine the actual effect.
• Some topical options (e.g., medical honey) have supported applications in surgical or wound care; other popular practices (systemic use of colloidal silver) carry demonstrated risks.
• There are no "natural antibiotics without contraindications": all treatments have potential effects and limitations.

LIMITATIONS OF EVIDENCE

Available studies include in vitro experiments, animal models, observational studies, and some small or heterogeneously designed clinical trials. In vitro studies describe mechanisms and potential activity but do not guarantee clinical results: experimental conditions (concentration, solvents, exposure duration) differ from human physiology. Observational studies report associations that do not establish causality. The variability of products (different botanical species, plant parts, extraction methods) limits generalizability. Finally, many clinical trials on supplements or natural remedies suffer from small sample sizes, lack of standardization, and risk of bias; therefore, well-designed and replicated clinical research is needed to define clear therapeutic roles.

Editorial Conclusion

The natural substances mentioned in the article show biological plausibility supported by experimental evidence. Some local applications and medical products (clinical-grade Manuka honey, silver-based dressings in selected contexts) can complement clinical practice, while other popular practices require caution. Informed choice must be based on product quality, clinical context, and risk assessment. In the absence of solid clinical data, it is prudent to consider these remedies as complementary, not substitutive, and always discuss them with your doctor.

Final Editorial Note

This article is an update of pre-existing content, created with scientific rigor and divulgative criteria. The purpose is informative; it does not constitute personalized medical advice. For diagnosis, therapies, or suspected infections, consult a healthcare professional.

SCIENTIFIC RESEARCH

1. Ankri S, Mirelman D. Antimicrobial properties of allicin from garlic. Microbes Infect. 1999;1(2):125–129. https://doi.org/10.1016/S1286-4579(99)80003-3
2. Cai Y, Wang R, Pei F, Liang B. Antibacterial activity of allicin alone and in combination with β-lactams against Staphylococcus spp. and Pseudomonas aeruginosa. J Antibiot (Tokyo). 2007;60:335–338. https://doi.org/10.1038/ja.2007.45
3. Kim JJ, Konkel K, McCulley L, Diak I-L. Cases of Argyria Associated With Colloidal Silver Use. Ann Pharmacother. 2019;53(8):867–870. https://doi.org/10.1177/1060028019844258
4. Knowles JR, Roller S, Murray DB, Naidu AS. Antimicrobial action of carvacrol at different stages of dual-species biofilm development by Staphylococcus aureus and Salmonella enterica serovar Typhimurium. Appl Environ Microbiol. 2005;71(2):797–803. https://doi.org/10.1128/AEM.71.2.797-803.2005
5. Veldhuizen EJ, Tjeerdsma-van Bokhoven JL, Zweijtzer C, Burt SA, Haagsman HP. Structural requirements for the antimicrobial activity of carvacrol. J Agric Food Chem. 2006;54(5):1874–1879. https://doi.org/10.1021/jf052564y
6. Review Group, Cochrane Acute Respiratory Infections Group. Echinacea for preventing and treating the common cold. Cochrane Database Syst Rev. 2014;(2):CD000530. https://doi.org/10.1002/14651858.CD000530.pub3
7. Jenkins R, Cooper R. Improving antibiotic activity against wound pathogens with Manuka honey in vitro. PLoS ONE. 2012;7(9):e45600. https://doi.org/10.1371/journal.pone.0045600
8. Müller P, Alber DG, Turnbull L, Schlothauer RC, Carter DA, et al. Synergism between Medihoney and rifampicin against methicillin-resistant Staphylococcus aureus (MRSA). PLoS ONE. 2013;8(2):e57679. https://doi.org/10.1371/journal.pone.0057679
9. Antimicrobial activity of commercial Olea europaea (olive) leaf extract. Int J Antimicrob Agents. 2009;33:461–463. https://doi.org/10.1016/j.ijantimicag.2008.10.026
10. Olive-leaf extract study: Olive-Leaf Extracts modulate inflammation and oxidative stress associated with H. pylori infection. Antioxidants. 2020;10:2030. https://doi.org/10.3390/antiox10122030
11. Ajami M, et al. Antimicrobial activity of eugenol and essential oils containing eugenol: a mechanistic viewpoint. Crit Rev Microbiol. 2017;43(6):1–[pages]. https://doi.org/10.1080/1040841X.2017.1295225
12. Hussain Y, Alam W, Ullah H, Dacrema M, Daglia M, Khan H, Arciola CR. Antimicrobial potential of curcumin: therapeutic potential and challenges to clinical applications. Antibiotics. 2022;11(3):322. https://doi.org/10.3390/antibiotics11030322